ROBIN SHERRINGTON - Insider Non-Derivative Transactions at Xenon Pharmaceuticals Inc. (XENE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 7, 2024, ROBIN SHERRINGTON's relationship to Xenon Pharmaceuticals Inc. (XENE) is Officer (EVP, Strategy & Innovation), and currently has 16,824 shares of Common Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other XENE insiders.
Data Source: SEC.
ROBIN SHERRINGTON - Insider Non-Derivative Transactions of XENE Common Shares
ROBIN SHERRINGTON - Insider Non-Derivative Transactions at XENE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 8, 2024 | Sell -- (Common Shares) | 6118 | 46.3 | 8398 |
| Mar 8, 2024 | F -- (Common Shares) | 215 | 45.96 | 9417 |
| Mar 8, 2024 | M -- (Common Shares) | 1234 | 9.85 | 9632 |
| Mar 8, 2024 | Sell -- (Common Shares) | 1019 | 46.15 | 14516 |
| Mar 8, 2024 | F -- (Common Shares) | 1289 | 45.96 | 15535 |
| Mar 8, 2024 | M -- (Common Shares) | 7407 | 9.85 | 16824 |
| Dec 30, 2023 | J -- (Common Shares) | 8398 | 0 | 8398 |